Could a simple capsule beat chemo fatigue? new trial aims to find out

NCT ID NCT07669467

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This Phase 3 trial tests whether Nuvastatic 300 mg capsules can reduce the crushing fatigue that often comes with chemotherapy. About 250 women with metastatic triple-negative breast cancer will take either the supplement or a placebo three times daily for 60 days while continuing standard chemo. Researchers will track changes in fatigue scores and quality of life to see if Nuvastatic offers real relief.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Nuvastatic 300 mg capsules (a botanical-based supplement)
What this could lead to
If it works, this could offer a safe, non-drug option to ease severe fatigue during chemotherapy for breast cancer patients.
What could go wrong
This is an early-stage Phase 3 trial with only 250 participants. Fatigue is subjective, and the placebo effect may be strong. The supplement may not outperform placebo.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Erode Cancer Care Centre

    RECRUITING

    Erode, Tamil Nadu, 638012, India

  • International Oncology Cancer Tower 1

    ACTIVE_NOT_RECRUITING

    Kanpur, Uttar Pradesh, India

  • Jeevanjyoti Cancer Hospital

    ACTIVE_NOT_RECRUITING

    Jalgaon, Maharashtra, 425001, India

  • K R Hospital

    ACTIVE_NOT_RECRUITING

    Mysore, Karnataka, 570001, India

  • Omega Hospital Chinna Gadhili

    RECRUITING

    Visakhapatnam, Andhra Pradesh, 530040, India

  • Sangavi Multispeciality Hospital Pvt. Ltd,

    RECRUITING

    Pune, Mahrasta, 411027, India

More trials for these conditions

Other studies related to the condition(s) this trial covers.